Request Deal Involvement
The Carlyle Group to acquire a 5% stake in Shenzhen Salubris Pharmaceuticals for $260m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
pr advisors
Ogilvy
or
Principals
target
SHENZHEN SALUBRIS PHARMACEUTICALS
bidder
THE CARLYLE GROUP
vendor
SALUBRIS (SUZHOU) PHARMACEUTICAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite